Replies to post #386174 on Innovation Pharmaceuticals Inc (IPIX)

[Minnesinger]

Once again, I think you're being impatient...

I'm skeptical we'll hear any post-scripts to the trial this year. If there are any positive secondary endpoints, it might be best to announce them after the holidays; especially as CV numbers escalate after all of the gatherings and festivities. Then again, maybe we'll get a 4:01pm PR on Christmas eve letting us know there's no gold in the pan, only pyrite...

On another note, remember when we were pilloried for suggesting, even hypothetically, selling at $1.46 before TL read out? Ahhh... memories...

[sunspotter]

"I'm hoping Brilacidin has an amazing secondary endpoint hidden in the mix from the COVID trial."

Even if it did, it wouldn't count, as it failed the primary.

It might give a hint on future research (who's paying for that, I wonder?) but no more than that.

[sunspotter]

“m hoping Brilacidin has an amazing secondary endpoint hidden in the mix from the COVID trial”

Once again secondary endpoints are automatically rendered invalid if the primary isn’t met.

I’m sure IPIX are doing some retrospective data dredging to see if they can paint a target around some existing bullet holes, but that’s quite a different thing to secondary endpoint data.